Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery

ACS Nano

Volumn 10, Issue 6, 2016, Pages 5759-5768

  Sun, Yao ^b,c,d   Ye, Xiongzhen ^a   Cai, Mingxiang ^b   Liu, Xiangning ^a   Xiao, Jia ^a   Zhang, Chenyang ^b   Wang, Yayu ^a   Yang, Li ^a   Liu, Jiafan ^a   Li, Shannai ^a   Kang, Chen ^d   Zhang, Bin ^d   Zhang, Qi ^b   Wang, Zuolin ^b,c   Hong, An ^a   Wang, Xiaogang ^a  

^a JINAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c Shanghai Engineering Research Center of Tooth Restoration and Regeneration   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

bone formation; gene delivery; osteoblast targeting peptide; osteoporosis therapy; polyurethane nanoparticle

Indexed keywords

DATA ENCAPSULATION; DISEASES; GENE THERAPY; GENE TRANSFER; GENES; NANOPARTICLES; NUCLEIC ACIDS; OSTEOBLASTS; PEPTIDES; POLYURETHANES;

BONE FORMATION; BONE MICROARCHITECTURE; DELIVERY SYSTEMS; DRUG DEVELOPMENT; GENE DELIVERY; NUCLEIC ACID DELIVERIES; OSTEOPOROSIS THERAPY; TARGETING PEPTIDES;

BONE;

MICRORNA; NANOPARTICLE; PEPTIDE; SMALL INTERFERING RNA;

ANIMAL; BONE DEVELOPMENT; CELL DIFFERENTIATION; MOUSE; OSTEOBLAST;

ANIMALS; CELL DIFFERENTIATION; MICE; MICRORNAS; NANOPARTICLES; OSTEOBLASTS; OSTEOGENESIS; PEPTIDES; RNA, SMALL INTERFERING;

EID: 84976605800     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.5b07828     Document Type: Article

References (51)

1. Sims, N. A.; Martin, T. J. Coupling The Activities of Bone Formation and Resorption: A Multitude of Signals within the Basic Multicellular Unit BoneKEy Rep. 2014, 3, 481 10.1038/bonekey.2013.215
2. Rachner, T. D.; Khosla, S.; Hofbauer, L. C. Osteoporosis: Now and the Future Lancet 2011, 377, 1276-1287 10.1016/S0140-6736(10)62349-5
3. Canalis, E. New Treatment Modalities in Osteoporosis Endocr Pract. 2010, 16, 855-863 10.4158/EP10048.RA
4. Daddona, P. E.; Matriano, J. A.; Mandema, J.; Maa, Y. F. Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis Pharm. Res. 2011, 28, 159-165 10.1007/s11095-010-0192-9
5. Delmas, P. D.; Ensrud, K. E.; Adachi, J. D.; Harper, K. D.; Sarkar, S.; Gennari, C.; Reginster, J. Y.; Pols, H. A.; Recker, R. R.; Harris, S. T.; Wu, W.; Genant, H. K. et al. Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial J. Clin. Endocrinol. Metab. 2002, 87, 3609-3617 10.1210/jcem.87.8.8750
6. Black, D. M.; Delmas, P. D.; Eastell, R.; Reid, I. R.; Boonen, S.; Cauley, J. A.; Cosman, F.; Lakatos, P.; Leung, P. C.; Man, Z. et al. R. Once-yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis N. Engl. J. Med. 2007, 356, 1809-1822 10.1056/NEJMoa067312
7. Yin, H.; Kanasty, R. L.; Eltoukhy, A. A.; Vegas, A. J.; Dorkin, J. R.; Anderson, D. G. Non-viral Vectors for Gene-Based Therapy Nat. Rev. Genet. 2014, 15, 541-555 10.1038/nrg3763
8. Mingozzi, F.; High, K. A. Therapeutic in Vivo Gene Transfer for Genetic Disease Using AAV: Progress and Challenges Nat. Rev. Genet. 2011, 12, 341-355 10.1038/nrg2988
9. Bessis, N.; GarciaCozar, F. J.; Boissier, M. C. Immune Responses to Gene Therapy Vectors: Influence on Vector Function and Effector Mechanisms Gene Ther. 2004, 11, S10-S17 10.1038/sj.gt.3302364
10. Waehler, R.; Russell, S. J.; Curiel, D. T. Engineering Targeted Viral Vectors for Gene Therapy Nat. Rev. Genet. 2007, 8, 573-587 10.1038/nrg2141
11. Kanasty, R.; Dorkin, J. R.; Vegas, A.; Anderson, D. Delivery Materials for siRNA Therapeutics Nat. Mater. 2013, 12, 967-977 10.1038/nmat3765
12. Field, L. D.; Delehanty, J. B.; Chen, Y.; Medintz, I. L. Peptides for Specifically Targeting Nanoparticles to Cellular Organelles: Quo Vadis Acc. Chem. Res. 2015, 48, 1380-1390 10.1021/ar500449v
13. Hilgenbrink, A. R.; Low, P. S. Folate Receptor-Mediated Drug Targeting: from Therapeutics to Diagnostics J. Pharm. Sci. 2005, 94, 2135-2146 10.1002/jps.20457
14. Wijagkanalan, W.; Kawakami, S.; Hashida, M. Glycosylated Carriers for Cell-Selective and Nuclear Delivery of Nucleic Acids Front. Biosci., Landmark Ed. 2011, 16, 2970-2987 10.2741/3892
15. Weinberg, W.; Frazier-Jessen, M.; Wu, W.; Weir, A.; Hartsough, M.; Keegan, P.; Fuchs, C. Development and Regulation of Monoclonal Antibody Products: Challenges and Opportunities Cancer Metastasis Rev. 2005, 24, 569-584 10.1007/s10555-005-6196-y
16. Wu, Z.; Tang, L.-J.; Zhang, X.-B.; Jiang, J.-H.; Tan, W. Aptamer-Modified Nanodrug Delivery Systems ACS Nano 2011, 5, 7696-7699 10.1021/nn2037384
17. Kamaly, N.; Xiao, Z.; Valencia, P. M.; Radovic-Moreno, A. F.; Farokhzad, O. C. Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation Chem. Soc. Rev. 2012, 41, 2971-3010 10.1039/c2cs15344k
18. Hobbs, S. K.; Monsky, W. L.; Yuan, F.; Roberts, W. G.; Griffith, L.; Torchilin, V. P.; Jain, R. K. Regulation of Transport Pathways in Tumor Vessels: Role of Tumor Type and Microenvironment Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 4607-4612 10.1073/pnas.95.8.4607
19. Blanco, E.; Shen, H.; Ferrari, M. Principles of Nanoparticle Design for Overcoming Biological Barriers to Drug Delivery Nat. Biotechnol. 2015, 33, 941-951 10.1038/nbt.3330
20. Low, S. A.; Kopeček, J. Targeting Polymer Therapeutics to Bone Adv. Drug Delivery Rev. 2012, 64, 1189-1204 10.1016/j.addr.2012.01.012
21. Wang, D.; Miller, S. C.; Kopečková, P.; Kopeček, J. Bone-Targeting Macromolecular Therapeutics Adv. Drug Delivery Rev. 2005, 57, 1049-1076 10.1016/j.addr.2004.12.011
22. Neale, J. R.; Richter, N. B.; Merten, K. E.; Grant Taylor, K.; Singh, S.; Waite, L. C.; Emery, N. K.; Smith, N. B.; Cai, J.; Pierce, W. M., Jr Bone Selective Effect of an Estradiol Conjugate with a Novel Tetracycline-Derived Bone-Targeting Agent Bioorg. Med. Chem. Lett. 2009, 19, 680-683 10.1016/j.bmcl.2008.12.051
23. Hirabayashi, H.; Fujisaki, J. Bone-Specific Drug Delivery Systems Clin. Pharmacokinet. 2003, 42, 1319-1330 10.2165/00003088-200342150-00002
24. Sekido, T.; Sakura, N.; Higashi, Y.; Miya, K.; Nitta, Y.; Nomura, M.; Sawanishi, H.; Morito, K.; Masamune, Y.; Kasugai, S. et al. Novel Drug Delivery System to Bone Using Acidic Oligopeptide: Pharmacokinetic Characteristics and Pharmacological Potential J. Drug Target. 2001, 9, 111-121 10.3109/10611860108997922
25. Kasugai, S.; Fujisawa, R.; Waki, Y.; Miyamoto, K.-I.; Ohya, K. Selective Drug Delivery System to Bone: Small Peptide (Asp)6 Conjugation J. Bone Miner. Res. 2000, 15, 936-943 10.1359/jbmr.2000.15.5.936
26. Yarbrough, D.; Hagerman, E.; Eckert, R.; He, J.; Choi, H.; Cao, N.; Le, K.; Hedger, J.; Qi, F.; Anderson, M. et al. Specific Binding and Mineralization of Calcified Surfaces by Small Peptides Calcif. Tissue Int. 2010, 86, 58-66 10.1007/s00223-009-9312-0
27. Liang, C.; Guo, B.; Wu, H.; Shao, N.; Li, D.; Liu, J.; Dang, L.; Wang, C.; Li, H.; Li, S. et al. Aptamer-Functionalized Lipid Nanoparticles Targeting Osteoblasts as a Novel RNA Interference-Based Bone Anabolic Strategy Nat. Med. 2015, 21, 288-294 10.1038/nm.3791
28. Perrin, D. D. Binding of Tetracyclines to Bone Nature 1965, 208, 787-788 10.1038/208787a0
29. Kay, M. I.; Young, R. A.; Posner, A. S. Crystal Structure of Hydroxyapatite Nature 1964, 204, 1050-1052 10.1038/2041050a0
30. Albert, A.; Rees, C. W. Avidity of the Tetracyclines for the Cations of Metals Nature 1956, 177, 433-434 10.1038/177433a0
31. Russell, R. G.; Watts, N. B.; Ebetino, F. H.; Rogers, M. J. Mechanisms of Action of Bisphosphonates: Similarities and Differences and Their Potential Influence on Clinical Efficacy Osteoporosis Int. 2008, 19, 733-759 10.1007/s00198-007-0540-8
32. Wang, D.; Miller, S. C.; Shlyakhtenko, L. S.; Portillo, A. M.; Liu, X.-M.; Papangkorn, K.; Kopečková, P.; Lyubchenko, Y.; Higuchi, W. I.; Kopeček, J. Osteotropic Peptide That Differentiates Functional Domains of the Skeleton Bioconjugate Chem. 2007, 18, 1375-1378 10.1021/bc7002132
33. Favus, M. J. Bisphosphonates for Osteoporosis N. Engl. J. Med. 2010, 363, 2027-2035 10.1056/NEJMct1004903
34. Zhang, G.; Guo, B. S.; Wu, H.; Tang, T.; Zhang, B. T.; Zheng, L. Z.; He, Y. X.; Yang, Z. J.; Pan, X. H.; Chow, H. et al. A Delivery System Targeting Bone Formation Surfaces to Facilitate Rnai-Based Anabolic Therapy Nat. Med. 2012, 18, 307-314 10.1038/nm.2617
35. Mallikaratchy, P. R.; Ruggiero, A.; Gardner, J. R.; Kuryavyi, V.; Maguire, W. F.; Heaney, M. L.; McDevitt, M. R.; Patel, D. J.; Scheinberg, D. A. A Multivalent DNA Aptamer Specific for the B-Cell Receptor on Human Lymphoma and Leukemia Nucleic Acids Res. 2011, 39, 2458-2469 10.1093/nar/gkq996
36. Horiuchi, K.; Amizuka, N.; Takeshita, S.; Takamatsu, H.; Katsuura, M.; Ozawa, H.; Toyama, Y.; Bonewald, L. F.; Kudo, A. Identification and Characterization of a Novel Protein, Periostin, with Restricted Expression to Periosteum and Periodontal Ligament and Increased Expression by Transforming Growth Factor β J. Bone Miner. Res. 1999, 14, 1239-1249 10.1359/jbmr.1999.14.7.1239
37. McGuire, M. J.; Li, S.; Brown, K. C. Biopanning of Phage Displayed Peptide Libraries for the Isolation of Cell-Specific Ligands Methods Mol. Biol. (Clifton, N.J.) 2009, 504, 291-321 10.1007/978-1-60327-569-9-18
38. McGuire, M. J.; Gray, B. P.; Li, S.; Cupka, D.; Byers, L. A.; Wu, L.; Rezaie, S.; Liu, Y. H.; Pattisapu, N.; Issac, J. et al. Identification and Characterization of a Suite of Tumor Targeting Peptides for Non-Small Cell Lung Cancer Sci. Rep. 2014, 4, 4480 10.1038/srep04480
39. Hofmeister, L. H.; Lee, S. H.; Norlander, A. E.; Montaniel, K. R.; Chen, W.; Harrison, D. G.; Sung, H. J. Phage-Display-Guided Nanocarrier Targeting to Atheroprone Vasculature ACS Nano 2015, 9 (4) 4435-4446 10.1021/acsnano.5b01048
40. Teranishi, Y.; Hur, J. Y.; Welander, H.; Franberg, J.; Aoki, M.; Winblad, B.; Frykman, S.; Tjernberg, L. O. Affinity Pulldown of -Secretase and Associated Proteins from Human and Rat Brain J. Cell Mol. Med. 2010, 14, 2675-2686 10.1111/j.1582-4934.2009.00907.x
41. Schiapparelli, L. M.; McClatchy, D. B.; Liu, H. H.; Sharma, P.; Yates, J. R.; Cline, H. T. Direct Detection of Biotinylated Proteins by Mass Spectrometry J. Proteome Res. 2014, 13, 3966-3978 10.1021/pr5002862
42. Mahanta, A. K.; Mittal, V.; Singh, N.; Dash, D.; Malik, S.; Kumar, M.; Maiti, P. Polyurethane-Grafted Chitosan as New Biomaterials for Controlled Drug Delivery Macromolecules 2015, 48, 2654-2666 10.1021/acs.macromol.5b00030
43. Wu, C.; Gong, F.; Pang, P.; Shen, M.; Zhu, K.; Cheng, D.; Liu, Z.; Shan, H. An RGD-Modified MRI-Visible Polymeric Vector for Targeted siRNA Delivery to Hepatocellular Carcinoma In Nude Mice PLoS One 2013, 8, e66416 10.1371/journal.pone.0066416
44. Choi, K. Y.; Silvestre, O. F.; Huang, X.; Hida, N.; Liu, G.; Ho, D. N.; Lee, S.; Lee, S. W.; Hong, J. I.; Chen, X. A Nanoparticle Formula for Delivering siRNA or miRNAs to Tumor Cells in Cell Culture and in Vivo Nat. Protoc. 2014, 9, 1900-1915 10.1038/nprot.2014.128
45. Ding, M.; Song, N.; He, X.; Li, J.; Zhou, L.; Tan, H.; Fu, Q.; Gu, Q. Toward the Next-Generation Nanomedicines: Design of Multifunctional Multiblock Polyurethanes for Effective Cancer Treatment ACS Nano 2013, 7, 1918-1928 10.1021/nn4002769
46. Su, S.; Tian, Y.; Li, Y.; Ding, Y.; Ji, T.; Wu, M.; Wu, Y.; Nie, G. ″Triple-Punch″ Strategy for Triple Negative Breast Cancer Therapy with Minimized Drug Dosage and Improved Antitumor Efficacy ACS Nano 2015, 9, 1367-1378 10.1021/nn505729m
47. Khatri, N.; Baradia, D.; Vhora, I.; Rathi, M.; Misra, A. cRGD Grafted Liposomes Containing Inorganic Nano-Precipitate Complexed siRNA for Intracellular Delivery in Cancer Cells J. Controlled Release 2014, 182, 45-57 10.1016/j.jconrel.2014.03.003
48. O'Brien, J.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the Alamar Blue (resazurin) Fluorescent Dye for the Assessment of Mammalian Cell Cytotoxicity Eur. J. Biochem. 2000, 267, 5421-5426 10.1046/j.1432-1327.2000.01606.x
49. Semple, S. C.; Akinc, A.; Chen, J.; Sandhu, A. P.; Mui, B. L.; Cho, C. K.; Sah, D. W.; Stebbing, D.; Crosley, E. J.; Yaworski, E. et al. Rational Design of Cationic Lipids for siRNA Delivery Nat. Biotechnol. 2010, 28, 172-176 10.1038/nbt.1602
50. Zhou, H. F.; Yan, H.; Pan, H.; Hou, K. K.; Akk, A.; Springer, L. E.; Hu, Y.; Allen, J. S.; Wickline, S. A.; Pham, C. T. Peptide-siRNA Nanocomplexes Targeting NF-B Subunit p65 Suppress Nascent Experimental Arthritis J. Clin. Invest. 2014, 124 (10) 4363-4374 10.1172/JCI75673
51. Iwaniec, U. T.; Wronski, T. J.; Liu, J.; Rivera, M. F.; Arzaga, R. R.; Hansen, G.; Brommage, R. PTH Stimulates Bone Formation in Mice Deficient in Lrp5 J. Bone Miner. Res. 2007, 22, 394-402 10.1359/jbmr.061118